InvestorsHub Logo
Followers 2
Posts 697
Boards Moderated 0
Alias Born 04/08/2008

Re: beentomyrasite post# 4169

Thursday, 09/16/2010 8:31:25 PM

Thursday, September 16, 2010 8:31:25 PM

Post# of 20669
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=54425675



If InoLife captures JUST 5% of the existing market share for Plavix and the 6M new prescriptions in the next 3 months, this is what the stock price would be at $250 cost:

$5.56

That's EBITDA, etc. But also without a multiple.

Lop off 40% for margin of error, and it's $3.34

Imagine if 50% market share, or 80%


legend:

5%Mkt share * 9M new Plavix users 3 months = 450,000

5%Mkt share * 48M Plavix users = 2.4M

128 OS